Related Experiment Video
Updated: Aug 6, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging
Weg M Ongkeko1, Yi An, Theresa S Chu
1Division of Head and Neck Surgery, Department of Surgery, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. wongkeko@ucsd.edu
Objectives:
The objectives of this study were to determine the effects of Gleevec on p63 expression in head and neck squamous cell carcinoma (HNSCC) cell lines and to investigate the role of Gleevec in regulating p63 stabilization under DNA-damaging conditions.
Methods:
Immunohistochemical staining was performed to determine p63 expression in HNSCC tissue. Annexin V staining was used to assess the effects of p63 on early apoptosis. Immunoblotting was used to examine the effects of Gleevec on p63 protein levels in HNSCC cell lines in response to DNA damage. Immunofluorescence staining was performed to study the expression pattern of p63 and c-Abl.
Results:
In HNSCC, p63 protein levels are induced by DNA-damaging agents, including ionizing radiation, doxorubicin, and ultraviolet light. We demonstrate that Gleevec reduces p63/DeltaNp63 expression in a dose-dependent manner in HNSCC and overrides the protein induction by DNA-damaging agents. Overexpression of c-Abl in the absence of Gleevec results in higher levels of p63 than those treated with Gleevec, implicating c-Abl kinase activity as a regulator of p63 protein stability.
Conclusions:
Gleevec downregulates p63/DeltaNp63 levels in HNSCC in a dose-dependent manner under both normal and DNA-damaging conditions. This downregulation can be explained by Gleevec's inhibition of c-Abl, which destabilizes p63. Based on our data, treating cancers with high expression of TAp63 with Gleevec may result in the unfavorable inhibition of a tumor suppressor, whereas downregulation of DeltaNp63 would be advantageous. Further development of antibodies that can discriminate between TAp63 and DeltaNp63 will be needed to determine the specific effects of Gleevec on p63 in HNSCC.
Insights
Gleevec reduces p63/DeltaNp63 expression in head and neck squamous cell carcinoma (HNSCC) by inhibiting c-Abl. This finding has implications for cancer treatment, suggesting Gleevec may suppress tumors with high TAp63.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- p63 is a key regulator in squamous cell carcinomas.
- p63 protein levels are modulated by DNA-damaging agents in head and neck squamous cell carcinoma (HNSCC).
- The role of Gleevec (imatinib) in regulating p63 stability in HNSCC is not fully understood.
Purpose of the Study:
- To determine the effects of Gleevec on p63 expression in HNSCC cell lines.
- To investigate Gleevec's role in p63 stabilization under DNA-damaging conditions.
- To elucidate the mechanism by which Gleevec affects p63 levels, focusing on the c-Abl pathway.
Main Methods:
- Immunohistochemistry to assess p63 expression in HNSCC tissues.
- Annexin V staining to evaluate p63's effect on apoptosis.
- Immunoblotting and immunofluorescence to analyze p63 and c-Abl protein levels and expression patterns in response to Gleevec and DNA damage.
Main Results:
- Gleevec dose-dependently reduces p63/DeltaNp63 expression in HNSCC cells.
- Gleevec overrides the induction of p63 by DNA-damaging agents.
- c-Abl kinase activity positively regulates p63 protein stability, and Gleevec inhibits this interaction.
Conclusions:
- Gleevec downregulates p63/DeltaNp63 in HNSCC under normal and DNA-damaging conditions by inhibiting c-Abl.
- Gleevec's effect on p63 isoforms (TAp63 vs. DeltaNp63) has differential implications for tumor suppression.
- Targeted therapies discriminating between p63 isoforms are needed for precise HNSCC treatment strategies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

